Condition
    Effectiveness 2/5

    Echinacea for Frequent Infections

    Meta-analyses point to a modest reduction in how often colds occur and how long they last, but the effect is small and several of the best-conducted trials found nothing at all. Preparation type explains much of the disagreement.

    Overview

    Meta-analyses point to a modest reduction in how often colds occur and how long they last, but the effect is small and several of the best-conducted trials found nothing at all. Preparation type explains much of the disagreement.

    Verdict

    Mixed evidence

    Small average benefit that may not be noticeable to any individual. Worth trying at onset; not worth relying on.

    How It Works

    Alkylamides in alcoholic extracts modulate CB2 receptors on immune cells and dampen the cytokine response that drives cold symptoms, while polysaccharide-rich pressed juices act mainly on macrophage activity. Neither mechanism prevents infection; both plausibly shorten it.

    Dosing & Protocol

    Typical dose

    Recommended dose
    900-3,000 mg/day of standardised extract at symptom onset
    Expected timeframe
    Within the first two to three days of an illness episode, if at all

    Protocol

    timing
    Begin within 24 hours of first symptoms
    duration
    7-10 days per episode
    starting dose
    300-500 mg standardised extract three times daily
    assessment point
    Judge across three or four illness episodes

    Evidence

    What the studies say

    Cochrane and subsequent pooled analyses converge on a small reduction in cold incidence, in the region of 10-20%, and a shortening of illness by roughly half a day to a day. Confidence intervals frequently cross the null. Trials separated by preparation show alcoholic E. purpurea extracts outperforming dried root products, but the largest rigorously blinded prevention trials — including one in university students — reported no benefit. The literature is large, heterogeneous and unresolved rather than negative.

    No studies are yet linked to both Echinacea and Frequent Infections.

    Safety

    Caveats

    Species, plant part and extraction method differ across products, so trial results do not transfer between brands. Prevention evidence is weaker than treatment evidence.

    Less likely to help if

    People with autoimmune disease should not take it at all. Those on immunosuppressants, and anyone with Asteraceae allergy, are also excluded.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.